Health Outcomes and Costs (HOC) in Lung Cancer (LC)

• Conditions: Lung Cancer

• Registration Number: NCT02363101
• Lead Sponsor: Instituto Nacional de Cancer, Brazil

Brief Summary

The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.

Detailed Description

The costs will be assessed by micro-costing approach. All procedures involved in lung cancer at diagnosis, staging, treatment and best supportive care will be assessed.

The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and EORTC-QLQ-LC13 in all different stages of lung cancer.

An utility measure will be considered. The preference values will be assessed via discrete choice experiment. Two scenarios will be designed and the lung cancer patients will be asked about the preferences.

Study Timeline

• Study First Submitted: 2015-02-09
• Study First Submitted QC: 2015-02-09
• Study First Posted: 2015-02-13
• Status Verified: 2015-03
• Study Start: 2015-03
• Last Update Submitted: 2015-03-03
• Last Update Posted: 2015-03-04
• Primary Completion: 2016-03
• Study Completion: 2016-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Clinical diagnosis of lung cancer disease
• Able to understand the overall concept of study and sign the written informed consent

Exclusion Criteria

• Illiterate
• Visible cognitive impaired
• Non-primary lung tumor

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Direct costs	one year	Direct costs related to each procedure involved on lung cancer
HRQoL	up to 30 days after the procedure
Preference values	cross sectional	Evaluate preference values in hypothetic scenarios

Trial Locations

Locations (1)

INCA - Instituto Nacional de Câncer; 🇧🇷 Rio de Janeiro, Brazil